✅ ANSWER KEY — all fields pre-filled. Use this to check your work.

Esophagus & Stomach Disease — Active Recall

← Back to Drill

GI15 — HoyaDocs GI Block | USMLE Step 1

📚 Linked Study Guide Open GI15: Esophagus & Stomach Disease alongside this drill for reference.
△ Warmup — Key Facts
MARGIN (ulcer edge; squamous cells — NOT the base)
Goblet cells (columnar intestinal metaplasia)
SCC = Middle third; Adenocarcinoma = Lower third / GEJ
Warthin-Starry stain; Antrum
c-KIT gain-of-function mutation; Imatinib (Gleevec)
Extranodal lymphoma site (55%); H. pylori eradication
LO 1 — Infectious Esophagitis
⚠️ On-Exam: HSV vs CMV biopsy differences — classic boards vignette. Know where to biopsy!
FeatureHSV EsophagitisCMV EsophagitisCandida Esophagitis
Ulcer morphology
Punched-out ulcers (discrete, well-defined borders)
Linear / serpiginous ulcers
White plaques / pseudomembranes
Cell type infected
Squamous epithelial cells (ulcer margin)
Endothelial cells and fibroblasts (ulcer base)
N/A (surface overgrowth)
Biopsy from
Ulcer MARGIN
Ulcer BASE
Surface / plaque
Inclusion body
Cowdry A: eosinophilic intranuclear inclusions; 3 M's — Molding, Multinucleation, Margination
Owl's eye: large basophilic intranuclear inclusion + smaller cytoplasmic inclusions
N/A
Key histologic finding
Multinucleated giant squamous cells with 3 M's at ulcer margin
Cytomegalic cells (2–4× enlarged) with owl's eye nuclei at ulcer base
Pseudohyphae + budding yeast (not true hyphae)
Special stain H&E (Cowdry A inclusions visible) H&E (owl's eye visible)
GMS (Gomori methenamine silver); also PAS stain
⚠ Biopsy tip: For HSV, sample the ulcer margin (squamous cells with Cowdry A inclusions). For CMV, sample the ulcer base (endothelial cells/fibroblasts with owl's eye nuclei). This distinction is tested directly.
LO 2 — GERD
AspectDetails
Primary mechanism
Transient LES (lower esophageal sphincter) relaxation — not just decreased LES tone
Histology: inflammatory cells
Neutrophils + eosinophils infiltrating squamous epithelium (also intraepithelial lymphocytes)
Histology: epithelial changes
Basal cell hyperplasia >15% epithelial thickness; elongated papillae >50–60% into epithelium
Complication progression
GERD → Esophageal stricture → Barrett's esophagus → Dysplasia → Adenocarcinoma
⚠ GERD histology: basal cell hyperplasia >15% epithelial thickness + elongated papillae >50–60% into epithelium = hallmarks even without visible inflammation. Eosinophils may be present but are not required.
LO 3 — Barrett's Esophagus
⚠️ On-Exam: Barrett's requires BOTH endoscopic (salmon tongues) AND histologic (goblet cells) criteria
FeatureBarrett's Esophagus
Macroscopic appearance
Salmon-colored tongues of mucosa extending above the GEJ; irregular Z-line on endoscopy
Histologic hallmark
Goblet cells (columnar intestinal metaplasia) — sine qua non; columnar epithelium replaces normal squamous
Diagnosis requires
Both endoscopic criteria (salmon tongues above GEJ) AND histologic criteria (goblet cells on biopsy)
Cancer risk
Precancerous → esophageal adenocarcinoma; progression: low-grade → high-grade dysplasia → adenocarcinoma
Esophageal Cancer Comparison
⚠️ On-Exam: Location + risk factors reliably distinguish SCC from adenocarcinoma
FeatureSquamous Cell Carcinoma (SCC)Adenocarcinoma
Location
Middle third of esophagus
Lower third / gastroesophageal junction (GEJ)
Risk factors
Alcohol, tobacco, achalasia, Plummer-Vinson syndrome, caustic/lye injury
Chronic GERD, Barrett's esophagus, obesity
Histology
Keratin (squamous) pearls; intercellular bridges (desmosomes)
Gland formation; mucin production
IHC markers
p63+, CK5/6+, mucin−
CK7+, mucin+, CDX2+ (intestinal differentiation)
Precursor lesion Squamous dysplasia
Barrett's esophagus (with progression through dysplasia)
⚠ HY associations: Plummer-Vinson syndrome (iron deficiency + esophageal webs + glossitis) → SCC risk. Achalasia → SCC from stasis/irritation. Lye / caustic ingestion → SCC (decades later).
LO 4–5 — Acute & Chronic Gastritis
FeatureAcute GastritisChronic Gastritis
Dominant cell type
Neutrophils (PMNs)
Lymphocytes + plasma cells
Common causes
NSAIDs, H. pylori (initial), alcohol, stress, uremia
H. pylori (#1 most common), autoimmune, bile reflux
Mucosal defect Erosion = partial thickness (within mucosa) May progress to ulcer = full thickness
Histologic progression Neutrophils → erosion
Chronic gastritis → Atrophic gastritis → Intestinal metaplasia → Gastric atrophy
⚠ Erosion vs Ulcer distinction: Erosion = partial-thickness mucosal loss (muscularis mucosae intact). Ulcer = full-thickness through muscularis mucosae into submucosa or deeper. Tested frequently in clinical vignettes.
LO 6 — H. pylori vs Autoimmune Gastritis
⚠️ On-Exam: Know acid levels, gastrin, location, stain, and sequelae for each type
FeatureH. pylori GastritisAutoimmune Gastritis
Location
Gastric antrum (antrum-predominant)
Body and fundus (corpus-predominant)
Antrum involvement Yes (antrum predominant)
No — antrum SPARED (G cells remain intact)
Inflammatory cells
Neutrophils + plasma cells (mixed acute and chronic)
Lymphocytes (CD4+ T-cell–mediated destruction of parietal cells)
Gastric acid
↑ or normal acid
↓↓ Acid (achlorhydria — parietal cell destruction)
Serum gastrin
Normal or ↓ gastrin
↑↑ Gastrin (antral G cells intact; no acid feedback inhibition)
Special stain / test
Warthin-Starry (silver stain); also CLO test, urea breath test
Anti-parietal cell Ab; anti-intrinsic factor Ab
Key sequelae
PUD (duodenal + gastric), adenocarcinoma, MALT lymphoma (DGUAM)
Pernicious anemia (B12 deficiency); carcinoid tumor (ECL hyperplasia from ↑ gastrin)
⚠ Autoimmune gastritis mechanism: destruction of parietal cells → ↓ intrinsic factor → ↓ B12 absorption → megaloblastic anemia (pernicious anemia). Also ↑↑ gastrin (from intact antral G cells) → ECL cell hyperplasia → carcinoid tumor risk.
LO 7–8 — Peptic Ulcer Disease
⚠️ On-Exam: 4-layer histology and PHP complications are classic Step 1 questions
CategoryDetails
Pathogenesis triad
↑ Acid secretion + ↓ Mucosal defense (↓ prostaglandins/mucus/HCO₃) + Altered gastric motility
#1 predisposing factor
H. pylori infection (causes 70–90% of duodenal ulcers)
#2 predisposing factor
NSAIDs — inhibit COX-1 → ↓ prostaglandins (PGE2) → ↓ mucus and bicarbonate
Curling ulcer
Severe burns → fluid shifts → splanchnic vasoconstriction → mucosal ischemia → acute stress ulcer
Cushing ulcer
CNS injury / ↑ ICP → vagal stimulation → ↑ ACh → ↑ acid hypersecretion → acute stress ulcer
ZE syndrome
Gastrinoma (duodenum/pancreas; MEN1) → ↑↑ gastrin → massive acid → multiple/distal ulcers + diarrhea
Microscopy: 4 layers (surface→deep)
1. Fibrinopurulent exudate → 2. Necrosis → 3. Granulation tissue → 4. Fibrous (collagenous) scar
Complications: PHP
P = Perforation (free air, peritonitis); H = Hemorrhage (gastroduodenal artery); P = Pyloric obstruction
PUD Treatment
IndicationRegimen / Drug
H. pylori eradication
Triple therapy: PPI + Clarithromycin + Amoxicillin (or Metronidazole) × 14 days
Acid suppression (primary)
PPIs (omeprazole, pantoprazole) — irreversibly inhibit H⁺/K⁺-ATPase proton pump; also H2 blockers
Mucosal protection agents
Sucralfate (binds ulcer base, physical barrier); Misoprostol (PGE1 analogue → ↑ mucus + HCO₃)
⚠ ZE (Zollinger-Ellison) syndrome: gastrinoma (duodenal wall or pancreas; part of MEN1) → ↑↑ gastrin → massive acid hypersecretion → ulcers in unusual locations (distal duodenum, jejunum) + secretory diarrhea. Serum gastrin >1000 pg/mL is diagnostic.
LO 9 — Gastric Cancer Precursors
CategoryExamples
Precancerous lesions (actual neoplastic change)
Epithelial dysplasia (low/high grade); gastric adenomatous polyps
Precancerous conditions (predisposing states)
Intestinal metaplasia, atrophic gastritis, H. pylori infection, pernicious anemia, Ménétrier disease
LO 10 — Gastric Carcinoma: Lauren Classification
⚠️ On-Exam: Intestinal vs diffuse — histology, location, demographics, prognosis all tested
FeatureIntestinal TypeDiffuse Type
Histology
Well-formed glands + goblet cells (tubular glandular pattern)
Signet ring cells — intracellular mucin pushes nucleus to periphery; no gland formation
Location in stomach
Antrum (pyloric region)
Body/fundus (diffuse involvement)
Gross pattern Nodular / ulcerating / fungating
Linitis plastica (leather bottle stomach) — rigid, thickened, non-distensible
Epidemiology
High-incidence areas (Japan, Chile, Korea); older males; better prognosis
Worldwide distribution; younger (<50 yo); equal M:F ratio; poor prognosis
Key precursor / mutation
Intestinal metaplasia → dysplasia; H. pylori infection; environmental/dietary factors
CDH1 mutation (E-cadherin loss → loss of cell–cell adhesion); also H. pylori
Prognosis
Relatively better prognosis (than diffuse type)
Poor prognosis; presents late; ~29% 5-year survival overall
Macroscopic Types of Gastric Cancer
Polypoid / exophytic nodular growth protruding into lumen
Central ulceration with raised/irregular edges (distinguish from benign peptic ulcer)
Large irregular mushroom-like mass projecting into gastric lumen
Diffuse signet ring cell infiltration of stomach wall → rigid non-distensible stomach; aka "leather bottle stomach"
⚠ Linitis plastica = diffuse infiltration of stomach wall by signet ring cells → rigid, thickened, non-distensible stomach ("leather bottle"). Associated with diffuse-type adenocarcinoma and extremely poor prognosis. Overall 5-year survival for gastric CA = ~29%.
LO 11 — GIST (Gastrointestinal Stromal Tumor)
⚠️ On-Exam: c-KIT mutation + imatinib = classic Step 1 targeted therapy question
FeatureDetails
Cell of origin
Interstitial cells of Cajal (pacemaker cells of the GI myenteric plexus)
#1 site in GI tract
Stomach (most common location for GIST in GI tract)
Driver mutation
c-KIT (CD117) gain-of-function mutation → constitutively active receptor tyrosine kinase
IHC markers (positive)
CD117 (c-KIT)+; DOG1 (anoctamin 1)+
IHC markers (negative)Desmin−, S-100− (distinguish from leiomyoma / schwannoma)
Targeted therapy
Imatinib (Gleevec) — tyrosine kinase inhibitor (TKI) targeting c-KIT and PDGFRA
Prognosis determined by
Mitotic rate (mitoses/50 HPF) + tumor size — both correlate with metastatic risk
LO 12 — Gastric MALT Lymphoma
FeatureDetails
Cell lineage
Low-grade marginal zone B-cell lymphoma
Stomach's significance
#1 site of extranodal lymphoma; accounts for ~55% of GI lymphomas
Low-grade histologic appearance
Resembles chronic gastritis histologically (easily overlooked on low-power)
High-grade histologic appearance
Resembles diffuse large B-cell lymphoma or carcinoma; requires systemic chemotherapy
First-line treatment (early low-grade)
H. pylori eradication (triple therapy) → complete remission; removes the antigenic stimulus driving B-cell proliferation
⚠ MALT lymphoma pathogenesis: H. pylori chronic antigen stimulation → B-cell proliferation in acquired mucosa-associated lymphoid tissue → MALT lymphoma. Eradicating the antigen (H. pylori) removes the proliferative stimulus → regression of early low-grade disease.
LO 13 — H. pylori Disease Summary
D=Duodenal ulcer; G=Gastric ulcer; U=Ulcerating gastritis; A=Adenocarcinoma; M=MALT lymphoma
WHO Class I carcinogen (definite human carcinogen)
Gram-negative; spiral / helical (curved rod)
Urease-positive → converts urea → NH₃ → ↑ local pH → enables colonization; basis of urea breath test and CLO test
USMLE-Style Practice Questions — Answers Shown
1. A 48-year-old HIV-positive man presents with dysphagia and odynophagia. Endoscopy shows a linear ulcer in the mid-esophagus. Biopsy taken from the ulcer base reveals enlarged cells with large basophilic intranuclear inclusions surrounded by a clear halo ("owl's eye"). Which organism is responsible?
A. HSV-1
B. CMV
C. Candida albicans
D. H. pylori
E. EBV
B. CMV. Owl's eye intranuclear inclusions in endothelial cells/fibroblasts at the ulcer base = CMV esophagitis. Linear ulcers are characteristic of CMV. HSV shows Cowdry A inclusions in squamous cells at the ulcer margin (punched-out ulcers). Candida shows pseudohyphae. (LO 1)
2. A 58-year-old man with 25 years of heartburn undergoes surveillance endoscopy revealing salmon-colored tongues of mucosa extending 3 cm above the gastroesophageal junction. Biopsy confirms columnar epithelium with goblet cells. What is the primary cancer risk of this condition?
A. Squamous cell carcinoma of the esophagus
B. Adenocarcinoma of the esophagus
C. Gastric adenocarcinoma
D. Esophageal MALT lymphoma
E. No malignant potential
B. Adenocarcinoma of the esophagus. Salmon tongues + goblet cells (intestinal metaplasia) = Barrett's esophagus. Requires both endoscopic AND histologic criteria. Barrett's is a precursor to esophageal adenocarcinoma (not SCC), progressing through low-grade → high-grade dysplasia → invasive carcinoma. (LO 3)
3. A 65-year-old man with a 40-pack-year history and chronic alcohol use presents with progressive dysphagia. Endoscopy reveals a mid-esophageal mass. Biopsy shows keratin pearls and intercellular bridges. Which IHC profile is expected?
A. p63+, CK5/6+, mucin−
B. CK7+, CDX2+, mucin+
C. CD117+, DOG1+, desmin−
D. CD20+, BCL2+
E. Chromogranin+, synaptophysin+
A. p63+, CK5/6+, mucin−. Keratin pearls + intercellular bridges = squamous cell carcinoma. Mid-esophagus + alcohol + tobacco = classic SCC setting. SCC is p63+ and CK5/6+ (squamous markers), mucin−. Adenocarcinoma (lower esophagus/GEJ, GERD/Barrett's) would be mucin+ with glands. (LO 3)
4. A 52-year-old woman has fatigue and macrocytic anemia. Labs: ↓ gastric acid, ↑↑ serum gastrin, anti-parietal cell antibodies (+), B12 deficient. Biopsy shows lymphocytic infiltrate in the gastric body and fundus with antrum sparing. What is the pathophysiology of her anemia?
A. H. pylori → mucosal bleeding → iron deficiency
B. Parietal cell destruction → ↓ intrinsic factor → ↓ B12 absorption
C. Antral G-cell hyperplasia → ↑ gastrin → folate deficiency
D. Intestinal metaplasia → ↓ iron absorption
E. NSAIDs → chronic occult bleeding → iron deficiency
B. Parietal cell destruction → ↓ intrinsic factor → ↓ B12 absorption. Autoimmune gastritis: T-cell–mediated destruction of parietal cells → loss of intrinsic factor → B12 malabsorption → megaloblastic (pernicious) anemia. Antrum sparing + ↑↑ gastrin + anti-parietal cell Ab confirm autoimmune gastritis. (LO 6)
5. A 50-year-old man with a known duodenal ulcer suddenly develops severe "board-like" rigid abdomen. Upright CXR shows free air under the diaphragm. Which complication occurred, and which structure is classically eroded by a posterior duodenal ulcer causing hemorrhage?
A. Perforation; gastroduodenal artery
B. Hemorrhage; splenic artery
C. Pyloric obstruction; left gastric artery
D. Perforation; inferior mesenteric artery
E. Hemorrhage; superior mesenteric vein
A. Perforation; gastroduodenal artery. Free air under diaphragm + acute peritonitis = perforation (P in PHP). Posterior duodenal ulcers classically erode the gastroduodenal artery → massive hemorrhage. PHP = Perforation, Hemorrhage (most common complication), Pyloric obstruction (from scarring/edema). (LO 8)
6. Gastric biopsy shows cells with a rim of mucin pushing the nucleus to the cell periphery ("signet ring" cells). The stomach is diffusely thickened and non-distensible on imaging ("leather bottle"). Which Lauren classification type is this, and what is the prognosis?
A. Intestinal type; relatively better prognosis
B. Diffuse type; poor prognosis
C. Intestinal type; poor prognosis
D. Diffuse type; relatively better prognosis
E. Mixed type; intermediate prognosis
B. Diffuse type; poor prognosis. Signet ring cells + linitis plastica (leather bottle stomach) = diffuse-type gastric carcinoma. Diffuse type: worldwide distribution, younger (<50 yo), equal M:F, associated with CDH1 (E-cadherin) mutation, poor prognosis. Intestinal type: glands/goblet cells, antrum, older males, high-incidence areas (Japan), better prognosis. (LO 10)
7. A 60-year-old presents with a 4-cm submucosal gastric mass. Biopsy shows spindle cells. IHC: CD117+, DOG1+, desmin−, S-100−. Which mutation drives this tumor, and what is the first-line targeted therapy?
A. BRAF V600E; vemurafenib
B. BCR-ABL; imatinib
C. c-KIT gain-of-function; imatinib
D. EGFR amplification; erlotinib
E. HER2 amplification; trastuzumab
C. c-KIT gain-of-function; imatinib. Submucosal spindle cell tumor + CD117 (c-KIT)+ + DOG1+ = GIST (gastrointestinal stromal tumor), arising from interstitial cells of Cajal. Most common in the stomach. c-KIT gain-of-function mutation → constitutively active tyrosine kinase → treated with imatinib (Gleevec). Prognosis determined by mitotic rate + tumor size. (LO 11)
8. A 64-year-old with known H. pylori infection is found on endoscopy to have a low-grade B-cell gastric lymphoma that histologically resembles chronic gastritis. What is the most appropriate first-line treatment for early-stage low-grade disease?
A. R-CHOP chemotherapy
B. Total gastrectomy
C. H. pylori eradication (triple therapy)
D. Radiation therapy alone
E. Rituximab monotherapy
C. H. pylori eradication (triple therapy). Low-grade gastric MALT lymphoma is antigen-driven by H. pylori. In early-stage disease, eradication of H. pylori removes the proliferative stimulus → complete remission. The stomach is the #1 site of extranodal lymphoma (55%). High-grade or refractory disease requires chemotherapy. (LO 12)